Drug Combination Increases Overall Survival in Patients With PIK3CA-Mutated Advanced Breast Cancer
June 03, 2025
June 03, 2025
BOSTON, Massachusetts, June 3 -- Mass General Brigham issued the following news release:
* * *
New Drug Combination Increases Overall Survival in Patients with PIK3CA-Mutated Advanced Breast Cancer
Mutations in the PIK3CA gene are a key driver of breast cancer and are present in 35-40% of hormone receptor-positive breast cancers. A recently completed phase 3 clinical trial, conducted by researchers at Mass General Brigham and collaborators, shows that combi . . .
* * *
New Drug Combination Increases Overall Survival in Patients with PIK3CA-Mutated Advanced Breast Cancer
Mutations in the PIK3CA gene are a key driver of breast cancer and are present in 35-40% of hormone receptor-positive breast cancers. A recently completed phase 3 clinical trial, conducted by researchers at Mass General Brigham and collaborators, shows that combi . . .